HAMILTON, BM / ACCESS Newswire / March 24, 2026 / Altamira Therapeutics ("Altamira" or the "Company") (OTCID:CYTOF) today announced that it will release its annual report and financial statements for ...
Altamira Therapeutics Ltd. (NASDAQ:CYTO) shares are trading higher Thursday after the company announced highlights from its NASAR clinical trial with Bentrio nasal spray were published in video format ...
Expanding nucleic acid delivery business with new applications Ongoing optimization of cost structure Advancing plans for spin-off of nucleic acid delivery business and continuing strategic ...
Altamira Technologies Corporation is an open source technology company that offers engineering and analytic services. The McLean, Virginia-based organization serves the defense, intelligence and ...
Advancing plans for spin-off of nucleic acid delivery business and continuing strategic repositioning "2025 was marked by substantial progress in our nucleic acid delivery business and in our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results